89 related articles for article (PubMed ID: 16315867)
1. [Radiation, 5-FU and OK-432: inhibitory effect of IL-10 and TGF-beta].
Okamoto M; Tano T; Oshikawa T; Ahmed SU; Sasai A; Kan S; Sato M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1556-8. PubMed ID: 16315867
[TBL] [Abstract][Full Text] [Related]
2. Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.
Tano T; Okamoto M; Kan S; Bando T; Goda H; Nakashiro K; Shimodaira S; Koido S; Homma S; Fujita T; Sato M; Yamashita N; Hamakawa H; Kawakami Y
Neoplasia; 2013 Jul; 15(7):805-14. PubMed ID: 23814492
[TBL] [Abstract][Full Text] [Related]
3. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
4. Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432.
Ohe G; Sasai A; Uchida D; Tamatani T; Nagai H; Miyamoto Y
Oncol Rep; 2013 Aug; 30(2):945-51. PubMed ID: 23685791
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
Babu S; Kumaraswami V; Nutman TB
Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
[TBL] [Abstract][Full Text] [Related]
6. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
Fujimoto T; Duda RB; Szilvasi A; Chen X; Mai M; O'Donnell MA
J Immunol; 1997 Jun; 158(12):5619-26. PubMed ID: 9190909
[TBL] [Abstract][Full Text] [Related]
7. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.
Santangelo C; Scipioni A; Marselli L; Marchetti P; Dotta F
Eur J Endocrinol; 2005 Mar; 152(3):485-9. PubMed ID: 15757867
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
[TBL] [Abstract][Full Text] [Related]
10. IFN-beta and TGF-beta differentially regulate IL-12 activity in human peripheral blood mononuclear cells.
Van Weyenbergh J; P Silva MP; Báfica A; Cardoso S; Wietzerbin J; Barral-Netto M
Immunol Lett; 2001 Jan; 75(2):117-22. PubMed ID: 11137135
[TBL] [Abstract][Full Text] [Related]
11. Effects of the streptococcal preparation OK-432 on in vitro cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis.
Yamashiki M; Nishimura A; Takase K; Nakano T; Kosaka Y
J Clin Lab Immunol; 1992; 38(2):73-82. PubMed ID: 1343350
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro.
Sakano S; Shimabukuro T; Ohmoto Y; Naito K
Urol Res; 1997; 25(4):239-45. PubMed ID: 9286031
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
14. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
Yu JH; Kim KH; Kim H
Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
17. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha is secreted by monocytes in transit to become macrophages, but not by peripheral blood monocytes, following OK-432 (lyophilized S. pyogenes) stimulation.
Olsnes C; Stavang H; Olofsson J; Aarstad HJ
Scand J Immunol; 2007 Dec; 66(6):684-93. PubMed ID: 18021366
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
20. SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells.
Hebenstreit D; Luft P; Schmiedlechner A; Duschl A; Horejs-Hoeck J
Mol Immunol; 2005 Feb; 42(3):295-303. PubMed ID: 15589317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
